Astellas, Amgen to pay $124.75M for False Claims Act violations


Pharmaceutical companies Astellas and Amgen will pay a total of $124.75 million to resolve allegations that they violated the False Claims Act by illegally paying the Medicare co-pays for their own high-priced drugs.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.